Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1379)
  2. Journal Article (1159)
  3. Review (129)
  4. Editorial (65)
  5. Research Letter (36)
  6. Correspondence (26)
  7. Book Section (25)
  8. Guidelines (13)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Hematology-Oncology Fellows (2763)
  2. Department of Medicine (2720)
  3. Solid Tumor Oncology Division (2017)
  4. Hematologic Malignancies, Division of (1337)
  5. GSK Faculty (1233)
  6. Department of Pathology and Laboratory Medicine (988)

More Groups

People
  1. Michael Berger (220)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (177)
  5. Sergio Giralt (171)
  6. David Solit (169)

More People

Years
  1. 2025 (223)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (645)
  2. Elsevier Inc. (344)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (241)
  5. Nature Publishing Group (202)
  6. Oxford University Press (157)

More Publishers

Results (2836)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Not so neutral lipids: Metabolic regulation of the pre-metastatic niche
    Editorial

    Schoenfeld, J. D.; Vardhana, S. A.
    Cell Metabolism (2022)

    Fulltext@MSK | Save
  • Precision oncology: 2022 in review
    Review

    Rosen, E.; Drilon, A.; Chakravarty, D.
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Phase I A study to evaluate GDC-6036 monotherapy in patients with non-small cell lung cancer (NSCLC) with KRAS G12C mutation
    Meeting Abstract

    Sacher, A.; Patel, M. R.; Miller, W. H. Jr; Desai, J.; Garralda, E.; Bowyer, S.; Kim, T. W.; De Miguel, M.; Falcon, A.; Krebs, M. G.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Delays in care following a COVID diagnosis
    Meeting Abstract

    Mullangi, S.; Aviki, E. M.; Chen, Y.; Robson, M. E.; Hershman, D. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Racial disparities in patients with TP53 mutated acute myeloid leukemia
    Meeting Abstract

    Badar, T.; Litzow, M. R.; Shallis, R.; Stahl, M.; Bewersdorf, J. P.; Saliba, A. N.; de Camargo Correia, G. S.; Patel, A. A.; Abaza, Y.; Murthy, G. S. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Craniocaudal nodal length (CCNL) as a risk-factor for relapse in stage I non-seminomatous germ cell tumors (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Fernandes, M. C.; Funt, S. A.; Bromberg, M.; Knezevic, A.; Nikolovski, I.; Feldman, D. R.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II randomized study comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Meeting Abstract

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Warner, A. B.; Yu, H. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy
    Meeting Abstract

    Wong, J. L.; Knorr, D.; Whiting, K.; Seshan, V. E.; Pietzak, E. J.; Donahue, T. F.; Cha, E. K.; Goh, A. C.; Smith, R.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term results of a phase 2 trial of crenolanib combined with 7+3 chemotherapy in adults with newly diagnosed FLT3 mutant AML
    Meeting Abstract

    Wang, E. S.; Goldberg, A. D.; Walter, R. B.; Collins, R.; Stone, R. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical activity of pembrolizumab monotherapy in diffuse malignant peritoneal mesothelioma
    Meeting Abstract

    Wang, X.; Offin, M.; Roshkovan, L.; Miura, J.; Ginsberg, M. S.; Ciunci, C. A.; Egger, J. V.; Walker, S.; Cercek, A.; Litzky, L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save